江蘇寧滬高速公路(00177.HK)合計增持江蘇銀行股份1.35億股
格隆匯12月2日丨江蘇寧滬高速公路(00177.HK)公告,截至本公告日,該公司、寧滬投資公司及寧常鎮溧公司通過二級市場合計增持江蘇銀行股份1.35億股,佔江蘇銀行總股本的1.17%。斥資約9.47億元。
本次增持後,公司及子公司寧滬投資公司、寧常鎮溧公司合計持有江蘇銀行3.35億股股份,佔江蘇銀行總股本的2.9%。
江蘇銀行近年來業績穩健,此次增持計劃是基於公司對江蘇銀行未來發展的信心和價值成長的認可,預計將對公司相關投資收益產生積極影響,有利於公司進一步提高資金的使用效率、降低公司財務成本,拓展公司盈利渠道,為廣大股東創造更大的價值,不存在損害公司股東,特別是中小股東利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.